Glenmark Pharma launches anti-diabetes drug Remogliflozin in India

-
Glenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.

from Stocks-Markets-Economic Times http://bit.ly/2Lc0JyS

Comments

Post a Comment

Popular posts from this blog

SGX Nifty up 120 points; here's what changed for market while you were sleeping

-
Image
Asian stocks were set to edge higher early on Thursday after big tech rallied on Wall Street and as President Joe Biden announced a multi-trillion-dollar infrastructure investment plan. Australian S&P/ASX 200 index rose 0.3 per cent in early trading, while Hong Kong's Hang Seng index rose 0.54 per cent.Japan's Nikkei225 index advanced 1.20 per cent. from Stocks-Markets-Economic Times https://ift.tt/2QNFFly
Read more